Literature DB >> 1866013

Are demented patients with Parkinson's disease accurately reflected in prevalence surveys? A survival analysis.

K Marder1, D Leung, M Tang, K Bell, G Dooneief, L Cote, Y Stern, R Mayeux.   

Abstract

We re-reviewed 257 patient records previously reviewed for an incidence study of dementia in Parkinson's disease (PD) to determine the frequency, date of death, and cause of death. We posited that if disease duration is shortened when dementia occurs, then dementia may be far more common than reflected in prevalence studies. There were 17 deaths among 65 demented patients and 28 deaths among 168 nondemented patients. When we matched a subset of the nondemented patients to the demented patients by age and disease duration distributions, the demented subjects had significantly more deaths (p less than 0.02), and survival among demented subjects was decreased (p less than 0.05). Dementia was a significant predictor of death in this sample. We conclude that dementia reduces survival in patients with PD. Incidence is a much better measure of dementia in PD than prevalence because shortened duration makes it less likely to detect dementia in prevalence surveys.

Entities:  

Mesh:

Year:  1991        PMID: 1866013     DOI: 10.1212/wnl.41.8.1240

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

Review 1.  Dementia and co-occurring chronic conditions: a systematic literature review to identify what is known and where are the gaps in the evidence?

Authors:  Mark B Snowden; Lesley E Steinman; Lucinda L Bryant; Monique M Cherrier; Kurt J Greenlund; Katherine H Leith; Cari Levy; Rebecca G Logsdon; Catherine Copeland; Mia Vogel; Lynda A Anderson; David C Atkins; Janice F Bell; Annette L Fitzpatrick
Journal:  Int J Geriatr Psychiatry       Date:  2017-02-01       Impact factor: 3.485

2.  Cause of Death Determined by Full-body Autopsy in Neuropathologically Diagnosed Dementias: The Biobank for Aging Studies of the University of Sao Paulo (BAS-USP), Brazil.

Authors:  Beatriz Astolfi Neves; Paula Villela Nunes; Roberta Diehl Rodriguez; Atmis Medeiros Haidar; Renata Elaine Paraizo Leite; Camila Nascimento; Carlos Augusto Pasqualucci; Ricardo Nitrini; Wilson Jacob-Filho; Beny Lafer; Lea Tenenholz Grinberg; Claudia Kimie Suemoto
Journal:  Alzheimer Dis Assoc Disord       Date:  2022-01-10       Impact factor: 2.357

3.  Motor symptoms at onset of Parkinson disease and risk for cognitive impairment and depression.

Authors:  Richard B Dewey; Aanchal Taneja; Shawn M McClintock; C Munro Cullum; Richard B Dewey; Ira Bernstein; Mustafa M Husain
Journal:  Cogn Behav Neurol       Date:  2012-09       Impact factor: 1.600

4.  Mortality in levodopa-treated Parkinson's disease.

Authors:  John C Morgan; Lillian J Currie; Madaline B Harrison; James P Bennett; Joel M Trugman; G Frederick Wooten
Journal:  Parkinsons Dis       Date:  2014-01-28

5.  Mild cognitive impairment, dementia and risk of mortality in essential tremor: A longitudinal prospective study of elders.

Authors:  Nikki Delgado; Daniella Iglesias Hernandez; Keith Radler; Edward D Huey; Stephanie Cosentino; Elan Louis
Journal:  J Neurol Sci       Date:  2021-07-02       Impact factor: 4.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.